Drug Type CAR-T |
Synonyms TmCD19-IL18 CAR T cells(Kite Pharma) |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), IL-18 modulators(Interleukin 18 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD19 positive Non-Hodgkin Lymphoma | Phase 1 | US | 13 Nov 2023 | |
CD19 positive Non-Hodgkin Lymphoma | Phase 1 | US | 13 Nov 2023 |